The study and its comparison
Sixteen people with foot ulcers were randomized to slow-release vitamin C or inactive placebo: seven versus nine participants. Half were vitamin-C-deficient at baseline. [1]
At eight weeks, ulcer-size reduction favored the vitamin group. However, when blood results became available at four weeks, deficient participants in either group were offered vitamin C and glucosamine. [1]
What the finding establishes
The later treatment change complicates a simple eight-week vitamin-versus-placebo interpretation. Small groups make the estimated benefit uncertain. Ulcer healing is not the same endpoint as clearing infection or preventing every amputation. Funding and conflicts were not established from the abstract. The trial does not justify substituting supplementation for wound assessment and care. [1]
A hypothetical distinction
Imagine deficient controls begin active treatment halfway through a study. The final comparison no longer reflects unchanged regimens throughout.
| Detail | Interpretation |
|---|---|
| Measured outcome | Keep the endpoint specific |
| Study preparation | Not every retail product |
| Remaining uncertainty | Not resolved by a mechanism |
Sources for this article
- Vitamin C improves healing of foot ulcers: a randomised, double-blind, placebo-controlled trial.
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.